The EPS projection of Pharmerica Corporation (NYSE:PMC) for quarter ended 2016-09-30 is $0.52. A week before, the EPS forecast was $0.52 against target of $0.52, a month earlier. This estimate stood at $0.52 60 days earlier versus forecast of $0.52 90 days earlier, confirming a deviation of 0%.
Pharmerica Corporation (NYSE:PMC) reported that 18 days ago, the positive EPS revisions were 1 and negative revisions at 0.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 1, 2, 0 and 2, respectively.
The downgrade of EPS estimates for Pharmerica Corporation (NYSE:PMC) in the preceding 120, 60, 30 and 90 days were 1, 0, 0 and 0, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of Pharmerica Corporation (NYSE:PMC) was $0.52. This projection was computed after accounting 2 calls. As reported on 2016-05-06 the EPS was $0.45. The change was $0.08, demonstrating a percentage deviation of 21.62%. The projections confirmed a standard deviation of 0.01.
Quarterly Sales Estimates
For the fiscal 2016, the yearly sales target for Pharmerica Corporation (NYSE:PMC) stands at $542.75 and the median estimate at $542.75. Almost 2 analysts announced their estimates.
The highest estimate is $550 while the lowest target is $535.5 showing standard deviation of 10.253%.
As many as 2 analysts released sales estimates reised in upside while 2 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 2 revised sales number projection on upside while 2 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 2 hiked sales estimations and 2 reduced sales forecast. Pharmerica Corporation (NYSE:PMC) stated that the change in forecast was -1.354%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...